Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03521908 · ClinicalTrials.gov registry record
A Study to Compare the Risk of a Major Bleeding in Participants Who Received Blood Thinning Medications Following a Blood Clot
A clinical trial of Venous Thromboembolism (VTE), sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- 35,756
- Enrollment target
- 1
- Study location
NCT03521908: Completed study of Venous Thromboembolism (VTE), sponsored by Bristol-Myers Squibb.
NCT03521908 is a study of Venous Thromboembolism (VTE) that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 35,756 participants, above the 3,520-participant average among 3 other Venous Thromboembolism (VTE) trials with a reported enrollment target (916% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03521908, a study of Venous Thromboembolism (VTE), has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- 35,756 participants
- Enrollment target
- 1
- Study location
Study Summary
A study to compare the risk of a major bleeding in participants who received 2 different blood thinning medications following a blood clot
Conditions Studied
Study Locations (1)
New Jersey
- Local Institution - Princeton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35,756 participants |
| Start Date | 2016-06-13 |
| Est. Completion | 2018-11-23 |
What the finished NCT03521908 record still lists
NCT03521908 is an observational study that tracks outcomes without assigning an intervention. Its 35,756 participants enrollment target places it among the larger protocols in the corpus, above the 3,520-participant average among 3 other Venous Thromboembolism (VTE) trials with a reported enrollment target (916% higher).
The record links to 1 condition, with Venous Thromboembolism (VTE) appearing as the primary indexed condition, and to 0 interventions.
NCT03521908 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT03521908 about?
NCT03521908 is a clinical study titled "A Study to Compare the Risk of a Major Bleeding in Participants Who Received Blood Thinning Medications Following a Blood Clot". A study to compare the risk of a major bleeding in participants who received 2 different blood thinning medications following a blood clot
What is the current status of trial NCT03521908?
This trial is currently completed. The enrollment target is 35,756 participants. The study started on 2016-06-13. Estimated completion is 2018-11-23.
What conditions does trial NCT03521908 study?
This clinical trial studies the following conditions: Venous Thromboembolism (VTE).
Who is sponsoring clinical trial NCT03521908?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03521908 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Venous Thromboembolism (VTE)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03262259 · 36,000 participants · NA
Evaluation of Global Smart Drinking Goals Initiative
- NCT07150923 · 36,503 participants · NA
Supraglottic Airway for Resuscitation Trial
- NCT02225301 · 35,000 participants · NA
iLookOut for Child Abuse -Online Learning Module for Early Childcare Providers
- NCT03720613 · 34,532 participants
Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI